Paris, France, Boston, USA, March 30 th, 2023-- TISSIUM, a privately-owned medical technology company developing biomorphic programmable polymers for atraumatic tissue reconstruction, announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results